Overexpression of metabolic markers PKM2 and LDH5 correlates with aggressive clinicopathological features and adverse patients’ prognosis in tongue cancer

Background: Pyruvate kinase M2 (PKM2) and lactate dehydrogenase 5 (LDH5) are two metabolic markers of cancer, which are frequently overexpressed in human cancers.